Darius M Moshfeghi, Audina M Berrocal. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabClinical Trials, Phase II as TopicDiffusion of InnovationHumansInfant, NewbornMulticenter Studies as TopicNeovascularization, Pathologic/etiologyNeovascularization, Pathologic/prevention & controlProspective StudiesRandomized Controlled Trials as TopicRetinopathy of Prematurity/complications
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2011 PMID: 21724044 DOI: 10.1016/j.ophtha.2011.04.028
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079